# Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg

> **NCT01926652** · PHASE1 · COMPLETED · sponsor: **Shin Poong Pharmaceutical Co. Ltd.** · enrollment: 34 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** candesartan cilexetil 32mg, amlodipine 10mg

## Key facts

- **NCT ID:** NCT01926652
- **Lead sponsor:** Shin Poong Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2013-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01926652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01926652, "Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01926652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*